Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics-Reference-Cited by-同舟云学术

Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics

Published:1990-09 Issue:1 Volume:240 Page:9-12
ISSN:0175-758X
Container-title:European Archives of Psychiatry and Clinical Neuroscience
language:en
Short-container-title:Eur Arch Psychiatry Clin Nuerosci

Author:

Altamura A. C.,Cavallaro R.,Regazzetti M. G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine,Psychiatry and Mental health,Neuropsychology and Physiological Psychology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/BF02190085.pdf

Reference16 articles.

1. Altamura AC (1988) The clinical use of anticholinergic drugs in neuroleptic induced extrapyramidal side effects. A controlversial issue. In: Nappi G, Hornykiewicz O, Agnoli A, Fariello RG, Klawans H (eds) Neurodegenerative disorders: the role played by endotoxins and xenobiotics. Raven Press, New York, pp 179–192

2. Baldessarini RJ, Cole JO, Davis JM, Gardos G, Preskorn SH, Simpson GM, Tarsy D (1980) Tardive dyskinesia: a task force report. American Psychiatric Press, Washington, DC

3. Barnes TRE, Kidger T, Gore SM (1983) Tardive dyskinesia: a three year follow-up study. Psychol Med 13:71–81

4. Casey DE (1987) Tardive dyskinesia. In: Meltzer H (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1411–1419

5. Casey DE, Keepers GA (1988) Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia. In: Casey DE, Christhensen AV (eds) Psychopharmacology: current trends. Springer, Berlin, pp 74–93

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia;Cochrane Database of Systematic Reviews;2022-11-24

2. Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study;Schizophrenia Research;2022-10

3. Neurobiological mechanisms associated with antipsychotic drug-induced dystonia;Journal of Psychopharmacology;2020-09-09

4. Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors;The World Journal of Biological Psychiatry;2019-01-09

5. Predictors of abnormal involuntary movement in an African schizophrenia population;J NEUROPSYCH CLIN N;2008